chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Four patients received an expired 30-day use by date booster dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Four patients received an expired 30-day use by date booster dose) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022J21A, 009C21A and 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Four patients received an expired 30-day use by date booster dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Four patients received an expired 30-day use by date booster dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication reported. Patients were not experiencing any symptoms after receiving the vaccine. HCP wanted data on efficacy of vaccines administered after 30-day use by date. It had been reported that no allergies. No Treatment medication reported.   This case was linked to MOD-2022-503162 (Patient Link).
This spontaneous report was received from a pharmacist and refers to a 73-years-old male. The patient had no pertinent medical history and had an allergy to opioid. On 07-MAY-2016, the patient was vaccinated with ZOSTAVAX (lot number: L028286, expiry date: 28-OCT-2016, subcutaneously). There was no concomitant therapy. On an unknown date, reported as: at the end of June 2016, the patient developed pain in his wrists. The joint pain extended to both knees and hips and has subsequently became widespread. The patient sought medical attention (office visit). The patient was treated by his unspecified physician with NAPROSYN and prednisone (manufacturer unknown). At the time of the report, the patient was recovering. The relatedness between the adverse event and the vaccination with ZOSTAVAX was not reported. Additional information is not expected, because there is no consent to follow up.
Had rash, itchy hands-rash on everywhere on body. Received vaccine on 09/22/09 and noticed itching and rash on 09/26/09.
Severe aching; cold clammy skin; profuse sweating; headache; dizziness; nausea; almost passed out; severe fatigue.
Mild erythema nodosum to R leg, multiple painful tender nodules, prescribing ibuprofen.  Pain started on 2/5, rash started on 2/6.  Still pending outcome
After second Moderna covid vaccine ,   1 1/2 weeks after second vaccine I  ended up with blood clots in right leg and right lung - hospital overnight stay.  Outcome is not good thanks to the covid caccine
Unable to swallow, lymph nodes on the same side as injection huge, swollen and painful, fever/chills, vomiting.  DX: Acute Pharyngitis, Laryngitis ... missed 2 weeks of work, still sick following 2 weeks.
Patient immediately had a metallic taste in his mouth that has lingered for these last 6 weeks.
Patient called on 9/27/19 stating she was experiencing a red spot, the size of a half dollar at the site of injection. Patient states that it is tender to the touch. It began on 9/24/19. It does not appear to be getting any worse. The only time she even notices it is if she bumps that area of her arm into something. I counseled her to watch it this weekend. If it gets worse or is not better by Monday, to give either us or her doctor a call.
This spontaneous report was received from a nurse refers to four unspecified patients of unknown age and gender. No pertinent medical history was reported. On an unknown date, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot # K018964 and expiration date 15-OCT-2016) (dos, route and lot# were not reported). No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Tingly lips and throat.  Red eyelids.  Self-administered benadryl and all symptoms resolved after monitoring for 1 hour.
Mother phoned 07/17/02 reporting fever 100.8 ax, Not feeling well, c/o sore left arm, Slept Ok, Using Tylenol and cool packs locally, Saw PMD as advised (07/18/02), 07/19/02-P.C to mother who states child seen by PMD, 07/18/02-was told it was a local reactions-had redness, swelling, rash and bruising of left arm.
I first started feeling weird pains in my body right after the vaccine. I felt a little dizzy at times on the way home . At home, nothing notable occurred. The next day, in the evening around 4:30pm I started feeling really dizzy and weird. I went home and I sat on the chair. I felt really weak and bad. I was not feeling right. For the next few days, I kept feeling weak and dizzy and bad. I felt extremely strange. I had headaches sometimes, I'd have pains on my neck sometimes. I started having diarrhea about 5 days after. The stomach issues would occur in the evening. but the diarrhea always came in the morning. My appetite also decreased. I also experienced brain fog. I had parts of my body that would feel hot as I am just sitting there.  Sometimes I experience pain on both sides of my abdomen. I kept hoping it would get better. I called my doctor about 5-7 days after. My doctor said to take Tylenol for several days, rest and drink plenty of fluids. The symptoms kept going so I called a few days later, I was told to do the same thing again. So, the symptoms kept going. I had this tingling in my head and pain. I called my doctor and made an appt on 4/15. I told them I was having weird headaches and tingling in my head along with the diarrhea. She thought it could be a virus. The blood work showed low iron. Another test determined I had anemia. I also did a stool card, which came back negative. I was prescribed ferro sulfate medicine. I recently got my blood checked and they said the anemia has improved. A lot of the symptoms have improved but I still am not back to myself. I can still sense something is off. I have a pressure feeling in my chest and back that comes and goes. I do not feel like myself prior to receiving the shot.
Case number PHHY2014US099496, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 531907) website on 08 Aug 2014. This report refers to a 18-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. He was vaccinated with MENVEO (batch number: M12100) intramuscularly into the left arm on 19 Feb 2014. It was reported that there was a temperature excursions of MENVEO vaccine. No adverse event was reported following this medication error.
Developed a large papular raised rash on back, shoulder and bi-lateral medial thighs
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: Pt stated she felt dizzy and pressure around her sinuses. Stated she felt room spinning. Pt felt pain at the injection site and behind her head. Pt declined ambulance or emergency services. PT stated she'd only had a cereal for breakfast. Gave PT glucose and her spouse gave her water. Spouse called the primary care MD for advice. MD agreed with RPH that PT should sit and wait out the symptoms and call her back if no change. After about 30 minutes PT and spouse stated she was feeling better.
The night of my vaccine I had fever and chills and the next day I had the same as well as I was very weak.  On that Monday I began having menstrual bleeding.  I was in already in menopausal stage, so this was startling.  On the following day I had inflammation under my right clavicle bone.  I continued to have nausea and fatigue.  On the next day I went to the doctor.  I had an ultrasound, and a lymph bundle was enlarged.  Doctors decided to monitor the lymph bundle and the bleeding.  In March of 2022 they did a second ultrasound of clavicle.  It is still enlarged.  I began seeing an OBGYN in February of 2022.  They did an ultrasound and did not find anything significant.  I saw her again in August.  I am still having a cycle, but it is not heavy as it was right after the vaccine.  At first, I was bleeding three weeks out every month.  Now it more like a normal but also some spotting in between.  I still have the lingering inflammation on my clavicle.  It is like a pocket of watery tissue.  It is not resolved but it is gradually getting smaller.  I have cramping and pain from my uterus.  I had a Paraguard Copper T380 IUD for the last 8 years at the time of the vaccine and have since then had it removed.  Also in the very beginning after the second dose I had issues with vascular pain and I saw a cardiologist.
Soreness in and under the armpit (left). Severe enough that it inhibits sleep.
significant local erythema & induration entire lt shoulder;lt area 14x12cm erythema, warmth, indurated;puncture wound noted deltoid;non painful, uses arm ok;DTP rxn vs early cellulitis;
03/28/2021 received shot. 04/08/2021 getting pains across left chest. 04/13/2021 rash started on chest. 04/14/2021 went to skin doctor and diagnosed with Shingles Doctor prescribed CALACLOVIR MCL 1 Gram 3x dy 10 days
pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 12-Aug-2021. On 11-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications provided by the reporter.  The patient gestation period was 17 weeks.   Most recent FOLLOW-UP information incorporated above includes: On 17-Mar-2021: Pregnancy data clean up
Stomach ache; rash; itchy; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158), via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 61-year-old), as a single dose for COVID-19 immunisation. Medical history included kidney disease. Concomitant medications were not reported. The patient previously took oxycodone hydrochloride; paracetamol (PERCOCET) and experienced allergy on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient experienced stomach ache, rash and itchy. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event stomach ache, rash and itchy was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
States she has had mental fogginess and difficulty focusing since vaccine administration.  Continues to the date of report (3/15/21)
Twelve hrs after vaccines, had dry cough, 4 days later progressed to chest pain, seen at hospital, CXR showed pneumonia ; and shingles rash developed (L) abdomen. The day she was seen for pneumonia! Both diagnosed by doctor.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPOSURE VIA EYE CONTACT (A vaccine spilled in the eye while taking second dose of Moderna Covid-19 Vaccine) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050c21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced EXPOSURE VIA EYE CONTACT (A vaccine spilled in the eye while taking second dose of Moderna Covid-19 Vaccine). At the time of the report, EXPOSURE VIA EYE CONTACT (A vaccine spilled in the eye while taking second dose of Moderna Covid-19 Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No treatment medications were reported.
suffered an intracranial hemorrhage; subdural hematoma; fell; skull fracture; hemorrhage to right cerebrum; This is a spontaneous report from a contactable physician from a Pfizer-sponsored program. An 85-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on 01Feb2021 at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the 1st vaccine dose on 01Feb2021. The patient fell on 13Feb2021 with findings of a skull fracture and hemorrhage to right cerebrum and suffered an intracranial hemorrhage and subdural hematoma. The patient was hospitalized and was discharged on 16Feb2021. Her platelets were fine when she was discharged from the hospital. The patient has been home for 2 days and is scheduled to have her second dose of the vaccine on 22Feb2021. The physician wanted to know if the patient should postpone the 2nd dose and for how long or should she keep her appointment. Can the second vaccine dose be postponed past 21 days (as in 6 weeks or past 6 weeks instead of 3?). The outcome of the events was unknown. The patient fell, hit her head and had a brain bleed and fractured the back of her skull; the physician stated that it's not because of the Covid vaccine.   Information on the lot/batch number has been requested.; Sender's Comments: In agreement with the reporting physician, the company considered that the fall and subsequent skull fracture, hemorrhage to right cerebrum, intracranial hemorrhage and subdural hematoma were due to an intercurrent accident, unrelated to suspect vaccine BNT162B2. There is no evidence or argument to suggest a causal relationship between BNT162B2 and the events.
straight line shingles; hurt my shoulder for; couldn´t lift my arm; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of no adverse event (Old shingles vaccine).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, several weeks after receiving Shingles vaccine, the patient experienced shingles, shoulder pain and injected limb mobility decreased. On an unknown date, the outcome of the shingles and injected limb mobility decreased were unknown and the outcome of the shoulder pain was recovered/resolved.   It was unknown if the reporter considered the shingles, shoulder pain and injected limb mobility decreased to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The new shingles vaccine actually hurt the patient's shoulder for months due to the way the patient was injected. The patient couldn't lift the arm without a lot of pain. Weeks later, the patient got a mild case of straight line shingles across face.  The patient further stated that shingles could blind you if it gets in your eyes. The patient's doctor recommended the new shingles vaccine to the patient.  The patient never went back for the second shot of the new vaccine.
This spontaneous report was received from a medical assistant and refers to an unspecified number of patients who on an unknown date were vaccinated with improperly stored ROTATEQ lot # K013868, expiration date 27-MAY-2016, orally. No adverse effects were reported. The outcome of incorrect product storage was unknown. No further information was provided. Additional information has been requested.
next to nose below right eye had the feeling of something burning/getting a feeling on face below her eye, it felt like a burning sensation; like an irritant on skin; hurt, next to my nose and as the night went on it stayed there, moving lower today; getting little red blister or some type of little things/like a little blister pustule thing, now inside lip/blisters started forming down her cheek, she can feel them still forming; getting little red blister or some type of little things/like a little blister pustule thing, now inside my lip/the blisters are down to her mouth now and there is even one inside her lip; getting little red blister or some type of little things/like a little blister pustule thing, now inside my lip/the blisters are down to her mouth now and there is even one inside her lip; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date not provided), via an unspecified route of administration on 17Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The caller was a retired nurse who reported that she got the covid vaccine yesterday afternoon on 17Jan2021. She reported that about 30 minutes after getting the vaccine on 17Jan2021 she noticed "that next to my nose below right eye I had the feeling of something burning, like an irritant on my skin, like jalapeno pepper juice or something. It hurt, next to my nose and as the night went on it stayed there, moving lower today and getting little red blister or some type of little things. I looked in the mirror, and it's like a little blister pustule thing, now inside my lip". Caller stated that she was trying to decide if she needs to go to Urgent Care. Caller states that she got home after getting the COVID vaccine, she was there for 15 minutes for observation and then within a half hour of her getting home afterwards, she started getting a feeling on her face below her eye, it felt like a burning sensation, like jalapeno pepper juice, like an irritant type burning. Caller states that little by little, blisters started forming down her cheek, she can feel them still forming. Caller states that the blisters are down to her mouth now and there is even one inside her lip. Caller was wondering if this vaccine triggered a shingles outbreak in her, even though she has never had shingles before. But caller stated that she knew people can pop out with shingles after something like this, but she was just speculating, she did not know for sure that it is shingles. The outcome of the events was unknown. This case reported as non-serious.  Information on the LOT/Batch number has been requested.
approx 10 min p/vax pt became unresponsive to verbal stimuli & extremities stiffened & relaxed x2. No loss bladder or bowel control.
01/20/21 @ 4:00 PM: Headache, fever, chills, and body aches for 2 day. Symptoms are resolved. Feeling well.
I tested positive for covid in the beginning of Jan; I tested positive for covid in the beginning of Jan; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date Sep2021 (Batch/Lot number: unknown) as dose 3 (booster), single, administration date Mar2021 (Batch/Lot number: unknown) as dose 2, single and administration date Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "I have 9 stents" (unspecified if ongoing), notes: I have 9 stents no insurance and no primary care provider. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "I tested positive for covid in the beginning of Jan". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (Jan2022) positive.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Pt's mother stated she developed a fever 102.6 the next day early AM accompanied with dizziness and body aches. Fever lasted 1 1/2 days. Treated with MOTRIN.
Patient was given second flu shot (AFLURIA) instead of PNEUMOVAX. No adverse event - reporting for documentation.
Pt states that she received the high dose FLUZONE vaccine on 9/22 around noon. At 2AM on 9/23, pt states she woke to profuse sweating and then fainted. Pt states she had no further problems and has recovered fully.
p/vax pt felt a little light headed p/leaving office;in lobby passed out to the floor;wears glasses, glasses cut under rt eye, small abrasion, sl swollen;ice applied to eye;
Chills; Mild headache; 2 hours prior to the 2nd dose, the patient self-medicated with 2 Acetaminophen 500 mg tablets to prevent side effects.; This is a spontaneous report received a contactable pharmacist. A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history and concomitant medication was not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number: unknown) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. It was reported that the patient received dose 1 and dose 2 (21 days later) of the Pfizer-BioNTech Covid-19 Vaccine. 2 hours prior to the 2nd dose, the patient self-medicated with 2 Acetaminophen 500 mg tablets to prevent side effects. Patient did experience chills (day 1 PM) and mild headache (day 2). No other side effects were experienced. Recent recommendations have come to light (news media) strongly advising against medicating with Acetaminophen pre-vaccine with fears that it may subdue or blunt the immune effect of the vaccine. Patient was concerned and asking what he should do. Specifically: Should he seek out a third Pfizer injection without Acetaminophen or seek out another 2 shots therapy (Moderna). The outcome of the events was unknown.   Information on Lot/Batch was not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information was expected.
patient experienced left side facial swelling the morning after she received her first dose and she could not open her left eye.